Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication

Journal of Gastroenterology

Volumn 49, Issue 3, 2014, Pages 427-435

  Nagata, Naoyoshi ^a   Akiyama, Junichi ^a   Marusawa, Hiroyuki ^b   Shimbo, Takuro ^a   Liu, Yi ^a   Igari, Toru ^a   Nakashima, Ryo ^a   Watanabe, Hidenobu ^c   Uemura, Naomi ^d   Chiba, Tsutomu ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Japan Cytology and Pathology Laboratory   (Japan)

^d National Center for Global Health and Medicine   (Japan)

Author keywords

Activation induced cytidine deaminase; Endoscopic biopsy; Helicobacter pylori; Intestinal metaplasia; Updated Sydney system

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; AMOXICILLIN; CARBON 13; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; RABEPRAZOLE; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE;

ADULT; AGED; ARTICLE; BACTERIAL CLEARANCE; CORRELATION ANALYSIS; DIGESTIVE ENDOSCOPE; DUODENUM ULCER; ERADICATION THERAPY; EVALUATION STUDY; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; HYPERPLASTIC POLYP; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONUCLEAR CELL; MULTIVARIATE ANALYSIS; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH POLYP; STOMACH ULCER; UREA BREATH TEST; COMPLICATION; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; METABOLISM; METAPLASIA; MICROBIOLOGY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STOMACH NEOPLASMS;

ADULT; AGED; CYTIDINE DEAMINASE; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LINEAR MODELS; MALE; METAPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 84897112342     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0808-z     Document Type: Article

References (36)

1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273-75.
2. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-131.
3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
4. Correa P. Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomark Prev. 2003;12:238s-41s. (Pubitemid 36428013)
5. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-81.
6. Rugge M, Genta RM, OLGA Group. Staging gastritis: an international proposal. Gastroenterology. 2005;129:1807-8.
7. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631-6. (Pubitemid 46662927)
8. Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150-8.
9. Costa AC, Figueiredo C, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2009;14(Suppl 1):15-20.
10. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol. 2009;44:239-48.
11. Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143:550-63.
12. Touati E, Michel V, Thiberge JM, et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003;124:1408-19. (Pubitemid 36531814)
13. Matsumoto Y, Marusawa H, Kinoshita K, et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007;13:470-6. (Pubitemid 46559833)
14. Matsumoto Y, Marusawa H, Kinoshita K, et al. Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer. Gastroenterology. 2010;139:1984-94.
15. Marusawa H, Chiba T. Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis. Curr Opin Immunol. 2010;22:442-7.
16. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392-7.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74. (Pubitemid 8054849)
18. Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257-68. (Pubitemid 40333545)
19. Shimizu T, Marusawa H, Endo Y. Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis. Cancer Sci. 2012;103:1201-6.
20. Takeda Y, Yashima K, Hayashi A, et al. Expression of AID, P53, and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer. World J Gastrointest Oncol. 2012;4:131-7.
21. Goto A, Hirahashi M, Osada M, et al. Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch. 2011;458:717-24.
22. van Den Brink GR, ten Kate FJ, Ponsioen CY, et al. Expression and activation of NF-kappa B in the antrum of the human stomach. J Immunol. 2000;164:3353-9. (Pubitemid 30149001)
23. Pathak SK, Basu S, Bhattacharyya A, et al. TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol. 2006;177:7950-8. (Pubitemid 44846311)
24. Yamauchi K, Choi IJ, Lu H, et al. Regulation of IL-18 in Helicobacter pylori infection. J Immunol. 2008;180:1207-16.
25. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2-9.
26. Genta RM, Graham DY. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol. 1993;28:924-8. (Pubitemid 23294769)
27. Kim CJ, Song JH, Cho YG, et al. Activation-induced cytidine deaminase expression in gastric cancer.TumourBiol. 2007;28:333-9. (Pubitemid 351567551)
28. Stolte M, Eidt S. Lymphoid follicles in antral mucosa: immune response to campylobacter pylori? J Clin Pathol. 1989;42:1269-71. (Pubitemid 20035913)
29. Naylor GM, Gotoda T, Dixon M, et al. Why does japan have a high incidence of gastric cancer? comparison of gastritis between UK and japanese patients. Gut. 2006;55:1545-52. (Pubitemid 44629199)
30. Matsuhisa T, Tsukui T. Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens. J Clin Biochem Nutr. 2012;50:217-21.
31. Morita S, Matsumoto Y, Okuyama S, et al. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. Carcinogenesis. 2011;32:1706-12.
32. Olearchyk AS. Gastric carcinoma. A critical review of 243 cases. Am J Gastroenterol. 1978;70:25-45. (Pubitemid 9016789)
33. Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009;151:121-8.
34. Ito M, Takata S, Tatsugami M, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009;44:365-71.
35. Ushijima T, Nakajima T, Maekita T. DNA methylation as a marker for the past and future. J Gastroenterol. 2006;41:401-7. (Pubitemid 43941905)
36. Tatemichi M, Hata H, Nakadate T. Ectopic expression of activation-induced cytidine deaminase caused by epigenetics modification. Oncol Rep. 2011;25:153-8.